Aequus Pharmaceuticals Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported revenue was CAD 0.30228 million compared to CAD 0.491821 million a year ago. Net loss was CAD 0.916886 million compared to CAD 0.621658 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.